Recent data indicate that stromal SRD5A2 promotes prostate growth in Benign Prostatic Hyperplasia (BPH) via a paracrine WNT5A-LEF1-IGF1 signaling axis. This evidence concerns the gene IGF1 and benign prostatic hyperplasia.